» Articles » PMID: 38454761

Factors Associated With Delay in Lung Cancer Diagnosis and Surgery in a Lung Cancer Screening Program

Overview
Date 2024 Mar 8
PMID 38454761
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Delays to biopsy and surgery after lung nodule detection can impact survival from lung cancer. The aim of this study was to identify factors associated with delay in a lung cancer screening (LCS) program.

Materials And Methods: We evaluated patients in an LCS program from May 2015 through October 2021 with a malignant lung nodule classified as lung CT screening reporting and data system (Lung-RADS) 4B/4X. A cutoff of more than 30 days between screening computed tomography (CT) and first tissue sampling and a cutoff of more than 60 days between screening CT and surgery were considered delayed. We evaluated the relationship between delays to first tissue sampling and surgery and patient sex, age, race, smoking status, median income by zip code, language, Lung-RADS category, and site of surgery (academic vs community hospital).

Results: A total of 185 lung cancers met the inclusion criteria, of which 150 underwent surgical resection. The median time from LCS CT to first tissue sampling was 42 days, and the median time from CT to surgery was 52 days. 127 (69%) patients experienced a first tissue sampling delay and 60 (40%) had a surgical delay. In multivariable analysis, active smoking status was associated with delay to first tissue sampling (odds ratio: 3.0, CI: 1.4-6.6, P = 0.005). Only performing enhanced diagnostic CT of the chest before surgery was associated with delayed lung cancer surgery (odds ratio: 30, CI: 3.6-252, P = 0.02). There was no statistically significant difference in delays with patients' sex, age, race, language, or Lung-RADS category.

Conclusion: Delays to first tissue sampling and surgery in a LCS program were associated with current smoking and performing diagnostic CT before surgery.

References
1.
Kanarek N, Hooker C, Mathieu L, Tsai H, Rudin C, Herman J . Survival after community diagnosis of early-stage non-small cell lung cancer. Am J Med. 2014; 127(5):443-9. PMC: 4601577. DOI: 10.1016/j.amjmed.2013.12.023. View

2.
Alberts W, Bepler G, Hazelton T, Ruckdeschel J, Williams Jr J . Lung cancer. Practice organization. Chest. 2003; 123(1 Suppl):332S-337S. DOI: 10.1378/chest.123.1_suppl.332s. View

3.
Oakes J, Rossi P . The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med. 2003; 56(4):769-84. DOI: 10.1016/s0277-9536(02)00073-4. View

4.
Detterbeck F, Zelman Lewis S, Diekemper R, Addrizzo-Harris D, Alberts W . Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5 Suppl):7S-37S. DOI: 10.1378/chest.12-2377. View

5.
Jeon J, Holford T, Levy D, Feuer E, Cao P, Tam J . Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach. Ann Intern Med. 2018; 169(10):684-693. PMC: 6242740. DOI: 10.7326/M18-1250. View